POLE and cancer: We prepared EBV-transformed cell lines from the primary lymphocytes of 3 patients bearing candidate variants (henceforth referred to as the POLD1/POLH cell line, POLE cell line, and POLK cell line) and from several age-and gender-matched cancer-free controls.